(Press-News.org) Alex Aliper, PhD, president of global clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine (“Insilico”) will present at the Systems Aging Gordon Research Conference, a leading international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research. On Wed., June 5, 10:40 am, Dr. Aliper will give a talk titled "Generative Artificial Intelligence and Next-Generation Robotics for Drug Discovery and Longevity Research."
The conference is being held June 2-7 at the Rey Don Jaime Grand Hotel in Barcelona and will focus on “Systems Modeling, Aging Biomarkers, and Longevity Interventions." It brings together scientists from diverse fields to discuss the latest aging biomarkers and approaches to identify and validate longevity interventions – including the use of AI and machine learning. Other featured speakers include noted Harvard genetics professor and longevity expert David Sinclair, PhD and Morten Scheibye-Knudsen, PhD, associate professor at the University of Copenhagen who studies the consequences of DNA damage and interventions. Dr. Scheibye-Knudsen helps guide the Aging Research and Drug Discovery conference in Copenhagen in August, where Insilico Medicine plays a key role.
Insilico’s AI algorithms have been trained on both aging and disease and its lead drug, INS018_055, is a potentially first-in-class AI-designed TNIK inhibitor being advanced as a treatment for the deadly lung disease idiopathic pulmonary fibrosis (IPF) and is currently in Phase II trials with patients. The journey of that drug is detailed in a recent paper in Nature Biotechnology. The Company has used its commercially available Pharma.AI platform, which includes generative biology, chemistry, and medicine, to produce a pipeline of 31 therapeutic assets in multiple disease areas, many of them aging-related, including fibrosis, cancer, and immunology.
Insilico researchers first identified TNIK as a therapeutic target utilizing a combination of multiple computational target discovery approaches while studying aging and fibrosis. In 2022, the Company published the hallmarks of aging assessment of multiple therapeutic targets ranked by novelty, confidence and druggability, showing that TNIK is implicated in multiple biological processes associated with aging-related diseases.
A recent research paper in Trends in Pharmacological Sciences from Dr. Aliper and other Insilico scientists along with ETH Zurich revealed that TNIK has broad therapeutic potential beyond fibrosis, including in cancer, obesity and Alzheimer’s. In 2023, the Company launched a 6th generation intelligent robotics lab in Suzhou BioBAY Industrial Park which combines its Pharma.AI platform with fully automated biological experiment functional modules – including automated experiments in high-throughput hit compound screening, hit-to-lead optimization, lead-to-preclinical candidate (PCC) confirmation, and translational research.
Dr. Aliper currently oversees a team developing the software behind many of Insilico’s therapeutic programs at the Company’s Quantum Computing and AI R&D Center in Masdar City in Abu Dhabi.
About Insilico Medicine
Insilico Medicine, a global clinical-stage biotechnology company powered by generative AI, connects biology, chemistry, and clinical trial analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and generating novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.com
END
Insilico Medicine President Alex Aliper, Ph.D. to present at Systems Aging Gordon Research Conference
2024-05-30
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
ESA announces recipients of 2024 Awards
2024-05-30
The Ecological Society of America is pleased to announce the winners of its 2024 awards, which recognize outstanding contributions to ecology in new discoveries, teaching, sustainability, diversity and lifelong commitment to the profession.
These awards are designed to not only reward past achievements, but also to inspire a broad audience of scientists, educators and students, opening the door to new insights and collaborations that will further the impact of ecological research.
“The Ecological Society of America is immensely proud to honor this year’s distinguished awardees,” said ESA President ...
Novel mobile air monitoring technology yields greater insight into post-disaster pollution levels
2024-05-30
A team including researchers from the Texas A&M University School of Public Health and School of Medicine has found that high resolution mass spectrometry could be a valuable tool for identifying and assessing air-borne contaminants produced by natural and man-made disasters. Their findings were published in the Journal of Exposure Science & Environmental Epidemiology.
The scientists used high resolution mass spectrometry—a highly accurate means of identifying molecular compounds in a sample—in fall 2023 to identify volatile organic ...
Human cervix modeled in microfluidic organ chip fills key women's health gap
2024-05-30
Human cervix modeled in microfluidic organ chip fills key women's health gap
Engineered cervix with in vivo-like mucus production, hormone sensitivity, and associated microbiome creates novel testbed for bacterial vaginosis therapeutics and other treatments
By Benjamin Boettner
(BOSTON) — Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women's health and affects more than 25% of reproductive-aged women. It is caused by pathogenic bacteria that push the healthy microbiomes in the female vagina and cervix – the small gatekeeper canal that connects the uteruns and vagina – into a state of imbalance known as dysbiosis. ...
People are altering decomposition rates in waterways
2024-05-30
Humans may be accelerating the rate at which organic matter decomposes in rivers and streams on a global scale, according to a new study from the University of Georgia, Oakland University and Kent State University.
That could pose a threat to biodiversity in waterways around the world and increase the amount of carbon in Earth’s atmosphere, potentially exacerbating climate change.
Published in Science, the study is the first to combine a global experiment and predictive modeling to illustrate how human impacts to waterways may contribute to the global climate crisis.
“Everyone in the world needs water,” ...
Studied on social media: The real-world impacts of factual but misleading content & the characteristics of “supersharers”
2024-05-30
Factual yet misleading vaccine content was 46 times more effective at driving vaccine hesitancy than flagged misinformation, reports a new study exploring real-world impacts of misinformation exposure. A second study aiming to better understand the characteristics of “supersharers” – a small group of individuals increasingly found to spread misinformation – reports that just over 2,000 supersharers on X (formally Twitter) spread 80% of the fake news during the 2020 US presidential election; the study involved a sample of more than 660,000 voters on X and uncovered that the supersharers were mainly middle-aged Republican women in conservative states.
Misinformation, ...
Why some nest-invading cuckoo birds have higher rates of speciation
2024-05-30
Cuckoos – which lay their eggs in nests of other birds – have higher speciation rates when they lay their eggs in a broader range of host bird species’ nests, a new study reports. This higher speciation rate is driven by host rejection and cuckoo selection for mimetic nestling traits. How new species arise is a fundamental question in biology. Coevolution between closely interacting species is thought to increase biodiversity and potentially explain the vast number of distinctly specialized species. However, evidence linking macroevolutionary patterns to microevolutionary ...
Living bioelectronic device monitors and manages psoriasis in mice
2024-05-30
Coupling skin bacteria-laden hydrogel and electronics, researchers have introduced the ABLE platform, a bioelectronics system that can deliver management and adaptive treatment of skin inflammation. They test this approach in a mouse model of psoriasis. The findings demonstrate the potential for clinical application of bioelectronics devices that promote drug-free therapeutic effects through a living hydrogel interface. “This amalgamation of living and synthetic components is a notable advance toward ...
Model reveals global patterns of organic decomposition in rivers
2024-05-30
Integrating big data and a coordinated global field experiment, researchers have developed a model that can predict the decomposition rate of organic matter in rivers worldwide. The global model estimates decomposition rates in rivers across vast understudied areas of Earth, revealing rapid decomposition across continental-scale areas dominated by human activities. Earth's terrestrial ecosystems generate over 100 billion tons of plant detritus annually, with its fate – long-term storage, mineralization to greenhouse gasses, or incorporation into food webs – determined by decomposition rates. This organic material is continually added to rivers ...
Is your coffee ‘not hot’ or ‘cold’? Observing how the brain processes negated adjectives
2024-05-30
Negating an adjective by placing ‘not’ in front of it affects the way our brains interpret its meaning, mitigating but not entirely inverting our interpretation of its definition. In a study published May 23rd in the open-access journal PLOS Biology, Arianna Zuanazzi at New York University, US, and colleagues offer insight into how the brain represents changes of meaning over time and offer new methods for further linguistic research.
The way the brain processes negated adjectives — ‘not bad’ or ‘not ...
New, modified CRISPR protein can fit inside virus used for gene therapy
2024-05-30
Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian Wang and colleagues at Wuhan University, China, present these findings May 23rd in the open-access journal PLOS Biology.
Recent years have seen an explosion of research attempting to harness CRISPR gene-editing systems—which are found naturally in many bacteria as a defense against viruses—so they can be used as potential treatments for human disease. These systems rely on so-called CRISPR-associated (Cas) proteins, with Cas9 and Cas12a being ...